Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Letters to Health Care Providers

Letters to Health Care Providers

                        2024 Letters to Health Care Providers
          2023 Letters to Health Care Providers
          2022 Letters to Health Care Providers
          2021 Letters to Health Care Providers Home
          Medical Devices
          Medical Device Safety
          Letters to Health Care Providers
          Potential Exposure to Certain Chemicals with Use of GE HealthCare EVair and EVair03 Compressors with Certain Ventilators – Letter to Health Care ProvidersLetters to Health Care Providers Potential Exposure to Certain Chemicals with Use of GE HealthCare EVair and EVair03 Compressors with Certain Ventilators – Letter to Health Care Providers
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintJanuary 9, 2024

The U.S. Food and Drug Administration (FDA) is alerting health care providers and facilities about the potential for exposure to certain chemicals that may be released when General Electric (GE) HealthCare accessory components called the EVair or EVair 03 (Jun-air) compressors are used with certain ventilators. Compressors are optional accessories for ventilators and used when wall air is not available.

On December 29, 2023, GE HealthCare issued an Urgent Medical Device Correction to inform users about the potential for elevated levels of formaldehyde based on preliminary testing when the EVair or Jun-Air optional compressors are used with the Carescape R860 or Engström Carestation/Pro ventilators, respectively.  GE HealthCare is continuing to evaluate the root cause for these elevated levels of formaldehyde.

The FDA is not aware of reports of adverse events due to this issue to date.

The FDA is issuing this letter to help ensure you are aware of the manufacturer's recall notice and the recommended actions.

Recommendations

Review the Urgent Medical Device Correction notice from GE HealthCare for the EVair and EVair 03 (Jun-Air) Compressors, which includes model numbers and Unique Device Identifier (UDI) information.
	Do not use EVair and EVair 03 (Jun-Air) compressors to supply air to ventilators for neonatal and infant patients (0-2 years of age).
	Be aware that GE HealthCare is lowering the maximum room air temperature for operation of the compressors from 40 degrees C (104 degrees F) to 30 degrees C (86 degrees F) to further reduce the potential for patient exposure to formaldehyde.
	Be aware that GE HealthCare is updating user instructions with the updated operating conditions (30 degrees C (86 degrees F) maximum room air temperature) and indications for use specifying that the compressors are not recommended for use with neonates and infants (0-2 years of age).
	Report any issues with use of the compressors to the FDA.Background

The EVair compressor is intended for use with a Carescape R860 ventilator as a supply of compressed air.

The EVair03 (Jun-Air) compressor is intended for use with an Engstrom Carestation/Pro ventilator as a supply of compressed air.

Exposure to elevated levels of formaldehyde may lead to problems such as neurological impairment or respiratory problems (such as asthma, decreased lung function, inflammation, or irritation), which is particularly concerning for neonates and infants (0-2 years of age) who may have immature pulmonary function or other coexisting conditions.

FDA Actions

The FDA is working with GE HealthCare to conduct additional testing to further evaluate this issue.

The FDA will continue to keep health care providers and the public informed if significant, new information or recommendations become available.

Unique Device Identifier (UDI)

The FDA established the unique device identification system to adequately identify medical devices sold in the United States from manufacturing through distribution to patient use. For more information on UDI, please visit Unique Device Identification System (UDI Systems).

Reporting Problems to the FDA

The FDA encourages health care providers to report any adverse events or suspected adverse events experienced with any medical device. Prompt reporting can help the FDA identify and better understand the risks associated with medical devices and improve patient safety.

Health care personnel employed by facilities that are subject to the FDA's User Facility Reporting Requirements should follow the reporting procedures established by their facilities.
	Voluntary reports can be submitted through MedWatch: The FDA Safety Information and Adverse Event Reporting program.
	Device manufacturers and user facilities must comply with the applicable Medical Device Reporting (MDR) regulations.Contact Information

If you have questions about this letter, contact the Division of Industry and Consumer Education (DICE).

                                                                                  Content current as of:
      01/09/2024
              
              
Regulated Product(s)
		 Medical DevicesLetters to Health Care Providers

          
                        2024 Letters to Health Care Providers
          2023 Letters to Health Care Providers
          2022 Letters to Health Care Providers
          2021 Letters to Health Care Providers
 Subscribe to Medical Device Safety and Recalls
                        Sign up to receive email updates on medical device recalls, safety communications, and other safety information.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop